Martine Zimmermann

Director · 4 filings · Latest: Sep 22, 2026

Candel Therapeutics, Inc.

LIGAND PHARMACEUTICALS INC

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
LGND	Martine Zimmermann	Director	Sep 10, 2026	Sale	$285.00	1,200	$342.0K	3,897	Sep 14 8:59 PM
LGND	MARTINE ZIMMERMANN	—	Sep 10, 2026	Proposed Sale	$285.00	1,200	$342.0K	—	Sep 10 8:01 PM